Exhibit 989 · Agency press release
FDA Launches Crackdown on Deceptive Drug Advertising (press release)
Today, the FDA is sending thousands of letters warning pharmaceutical companies to remove misleading ads and issuing approximately 100 cease-and-desist letters to companies with deceptive ads.
Announces thousands of letters to pharmaceutical companies, about 100 cease-and-desist letters, and rulemaking to remove the “adequate provision” option created in 1997. States that FDA once sent more than a hundred warning letters a year and that those to pharmaceutical companies fell to one in 2023 and zero in 2024. Quotes the Commissioner: drug companies spend up to 25% of their budget on advertising. Letter counts are FDA’s own and were not independently checked.
- Source
- U.S. Food and Drug Administration
- Date
- 9 September 2025
- Quoted from
- Para. 1
- Grade
- Primary record
- Document
- https://www.fda.gov/news-events/press-announcements/fda-launches-crackdown-deceptive-drug-advertising
- Accessed
- 2026-11-10
- Cited by
- Findings citing this exhibit